Chin Augmentation in Prague Czech Republic
Plastic surgeons use implants to emphasize your face. The implants will create a harmonic appearance of your face allowing you to feel better about yourself. There are many types of implants made of different material. They can emphasize the jaw line, the checks and create a better proportions between the chin and the checks.
The surgeons use implants to achieve a better balance and create a younger look. Chin augmentation also called mentoplasty. The operation aimed to shape the chin by making it smaller or bigger. A larger chin can be created by an implant insertion or by surgery, which elongates the lower jaw. Smaller chin is made by reducing the size of the lower jaw. In many cases the surgeon will recommend mentoplasty for patients undergoing nose surgery in order to fit the new nose to the face, creating more harmonic appearance. When looked from the side the nose size should fit the chin.
The implant insertion may last from 30 minutes to one hour. The surgeon will design the implant that fits your chin and then inserted it to a "pocket" located in front of the chin. A small cut for the insertion can be made inside the mouse near the lower lip or from the outside just below the chin. After the procedure the chin is bandaged using plasters to prevent swelling and implant movement. Bandages also help prevent uncomfortable felling. The stitches can be removed after 5-7 days. In case the cut is made inside the mouse melting stitches are used and there is no need to remove them. The surgery can be done using local anesthetics with sedative drugs and sometimes with general anesthesia.
Every operation has its ricks. The implant may move from the original place. Then you need to undergo additional procedure to replace it. Infection is rare, it can be treated with antibiotics and in some cases the infected implant will be removed and replaced by another one.
After the surgery there is a strange felling around the chin. It is normal to fell difficulties in talking, smiling and eating. There may be blue marks around the chin and neck. It is advisable not to participate in activities which may harm the chin. The surgeon will guide you regarding dental hygiene and eating.
The final results may take weeks and even month to notice, therefore you must be patient.
More Prague info...
Prague Eat Individual listings can be found in Prague's district articles
Lunch is traditionally the main meal. Czech cuisine is typically based around pork or beef with starchy side dishes such as dumplings or fries. Fish is not so popular, though these days it is widely available. Popular Czech desserts include fruit dumplings, cr?pes or ice cream. Most restaurants become very crowded during lunch and dinner, so consider making a reservation or eating earlier than the locals.
-
Prague River cruises Prague Boat
River cruises are both popular and varied, from one hour cruises to long evening cruises with dinner or music.
-
Plastic Surgery News...
- The following statement was made by Richard Frankenstein, M.D., president of the California Medical Association "We are here not to rejoice in the demise of another health reform plan, but to praise the efforts of those who have worked to further its important goals, and to declare our hope for and continued commitment to health reform in the near future.
- Following a report from an observational study that the activity of clopidogrel on platelets, tested by vasodilator-stimulated phosphoprotein (VASP) phosphorylation was diminished in patients receiving PPI treatment, the OCLA (Omeprazole CLopidogrel Aspirin) study examined the influence of omeprazole on the antiplatelet activity of clopidogrel.
This double-blind placebo-controlled trial involved 124 consecutive patients undergoing coronary artery stent implantation, who received aspirin (75mg/day) and clopidogrel (loading dose, followed by 75mg/day). They were randomised to either omeprazole (20 mg/day) or placebo for 7 days. The effect of clopidogrel was tested on days 1 and 7 in both groups by measuring platelet phosphorylated-VASP expressed as a platelet reactivity index (PRI). The main end point was PRI value at the 7-day treatment period in the 2 groups. The study found that:
• On day 1, mean PRI was 83.2% and 83.9%, respectively, in the placebo and omeprazole groups (p = NS).
• On day 7, mean PRI was 39.8% and 51.4%, respectively, in the placebo and omeprazole groups (p < 0.0001).
The researchers conclude from these findings that omeprazole decreased the antiplatelet effect of clopidogrel as assessed by the VASP phosphorylation test. They note that as aspirin-clopidogrel antiplatelet dual therapy is widely prescribed, with PPIs frequently added to prevent GI bleeding, their findings require further evaluation, as the clinical impact of these results remains uncertain.
According to an accompanying editorial, this is a hypothesis-generating study. It adds that “improved patient selection and pharmokinetic/pharmacodynamic investigations are needed before any clinical significance can be attributed to this reported drug–drug interaction or any suggestions are made that cardiologists should delete omeprazole therapy when clinically indicated in patients treated with dual antiplatelet therapy.”